E. Fonseca Aizpuru

WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity Scales

J. Díez-Manglano, F. Formiga, J. Ena, 2022, Journal of General Internal Medicine.

Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial

F. Sánchez‐Madrid, L. J. Jiménez-Borreguero, C. Suárez, 2022, Scientific Reports.

Use of glucocorticoids megadoses in SARS-CoV-2 infection in a spanish registry: SEMI-COVID-19

M. Rubio-Rivas, A. Artero, J. Millán Núñez-Cortés, 2022, PloS one.

Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study

M. Rubio-Rivas, J. Millán Núñez-Cortés, C. Josa-Laorden, 2021, Journal of clinical medicine.

Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19

M. Freire, L. Pallarés, S. Prieto-González, 2023, JAMA network open.

Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Network.

R. Gómez Huelgas, M. Rubio-Rivas, E. Roy-Vallejo, 2020 .